BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RHG, Toller W, Tritapepe L, Tschöpe C, Wikström G, Lewinski DV, Vrtovec B, Pollesello P. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use. J Cardiovasc Pharmacol 2020;76:4-22. [PMID: 32639325 DOI: 10.1097/FJC.0000000000000859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hullin R, Meyer P, Yerly P, Kirsch M. Cardiac Surgery in Advanced Heart Failure. J Clin Med 2022;11:773. [PMID: 35160225 DOI: 10.3390/jcm11030773] [Reference Citation Analysis]
2 Xie Y, Xing Z, Wei J, Sun X, Zhao B, Chen Y, Geng Y, Jia Z, Zou H, M.a B. Levosimendan Postconditioning Attenuates Cardiomyocyte Apoptosis after Myocardial Infarction. Journal of Healthcare Engineering 2022;2022:1-9. [DOI: 10.1155/2022/2988756] [Reference Citation Analysis]
3 Weisert M, Su JA, Menteer J, Shaddy RE, Kantor PF. Drug Treatment of Heart Failure in Children: Gaps and Opportunities. Paediatr Drugs 2022. [PMID: 35084696 DOI: 10.1007/s40272-021-00485-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cai F, Kampourakis T, Klein BA, Sykes BD. A Potent Fluorescent Reversible-Covalent Inhibitor of Cardiac Muscle Contraction. ACS Med Chem Lett 2021;12:1503-7. [PMID: 34531960 DOI: 10.1021/acsmedchemlett.1c00366] [Reference Citation Analysis]
5 Riessen R, Hellwege RS. [Pharmacological therapy of circulatory shock]. Med Klin Intensivmed Notfmed 2021;116:541-53. [PMID: 34338810 DOI: 10.1007/s00063-021-00838-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]